Our findings highlight PTBP3 as a crucial oncogenic splicing factor, and targeting the alternative splicing events regulated by PTBP3 could serve as an effective therapeutic strategy for peritoneal metastasis in gastric cancer. Here, PTBP3 is linked to gastric cancer.